Apnimed, Inc., a late stage clinical pharmaceutical company dedicated to the discovery, development, and commercialization of novel oral therapies that address the neurobiology of sleep-related...

The premier academic health system makes a foundational infrastructure decision to transform radiology reporting, embracing the next era of diagnostic medicine NEW HAVEN, Conn. and SAN FRANCISCO,...

The conference in Thailand this year will reveal why, if you want to understand the future of wellness, you need to understand the Asian market—from the region's innovations in driving longer...

Robo.ai Inc. (NASDAQ: AIIO) today announced the appointment of Emirati executive Mr. Rashed Aleghfeli as Chief Operating Officer (COO) of its wholly-owned data processing and compression...

Immunic, Inc. (Nasdaq: IMUX), a late-stage biotechnology company pioneering the development of novel oral therapies for neurologic diseases, today announced participation in the following...